FDA NDC Directory · JSON-LD · Markdown

Krystexxa

NDC 75987-058 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namepegloticase
Labeler / ManufacturerHorizon Therapeutics USA, Inc.
Marketing categoryBiologic License Application · App BLA125293
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsPEGLOTICASE (8 mg/50mL)
Marketing started20250829
Package count1

External sources

Source: openFDA. Public-domain (CC0).